Registered Charity No. 1088008.
  Andropause
  Lectures
  Primary Care  
 

International  

 

Reviews

 

Lay Forum

 

Reference Library

 

Bibliography 

  Other News
  Payments
  Member Search
  Edit your details
 
  Conference 2005
  Conference 2003
  Training
 
  Events Diary
   
 
Help Centre - Questionnaire, Forum, Doctors, Books
 
  Legal
  Contact
  Search the Site

 

Canada Latest News from the Canadian Andropause Society  
Australia The Andropause Society of Australia and the fight for HRT  
USA Developments in USA

THE FIGHT FOR MALE HRT IN AUSTRALIA - TEST CASE

The Andropause Society of Australia

The fight for HRT in Australia

The legal proceedings

A test case

Linda Byart

A NEW INITIATIVE RELATING TO AN INDIVIDUAL CASE

In a different initiative, a request was made to the Administrative Appeals Tribunal using a single man as a test case, to review a Government decision to refuse him PBS medication twice requested by his doctor on compelling medical grounds. This was lodged on 20 October 2000.

Case History: Peter Allen

Peter Allen is now 51 years old, but classic symptoms of androgen deficiency: began to develop in his early 40’s - namely fatigue, mental cloudiness with gradual loss of ability to concentrate, irritability and reduced capacity for coping with any stress or pressure, as well as loss of sex drive.

He has 2 high risk indicators in his past that could account for the onset of symptoms - a vasectomy and exposure to both farming and cleaning chemicals. He is an asthmatic and was also on medication for a hiatus hernia (oesophagitus).

As the symptoms worsened, he was unable to keep up with his duties as a Caravan Park Manager and eventually lost his job.

He continued to deteriorate until September 1998 when he and his doctor, with assistance and guidance of STAG (now TIME FOR MEN) began to explore Hormone supplementation (HRT) for him according to international guidelines, with a degree of success.

In May 1999 Peter had 6 x 200 slow release testosterone pellets implanted into his buttock, again according to the international protocols made available through TIME FOR MEN. The benefits of such an implant usually lasts from 4-6 months.

At that time he qualified for subsidy under the Pharmaceutical Benefits Scheme having been diagnosed as ‘hypogonadal’ by his doctor. This was what was needed to qualify prior to the August 1199 changes. Because he had a Health Care Card the prescription cost him just $3.20. Without a card his cost on subsidy would have been $20.60

He rapidly began to recover his health. His sense of well being returned. He was again able to do things around the house and to assume responsibility as a Full Time Carer for his wife, who is on a Disability Support Pension. There was a gradual return of sexual function. His asthma cleared up. He no longer needed to take medication for his cesophagitus and there was an overall dramatic improvement in physical, emotional and mental wellbeing and functioning.

His wife comments that he became an affectionate partner again - not just sexually but also in giving her a spontaneous hug which she had missed. With the onset of his symptoms he had become withdrawn from her and antisocialgenerally. There was a Jack of desire and lack of any affection or physical contact, so that she felt emotionally deprived and was constantly worrying at what was happening to him. She had watched him deteriorating in his job and how he had struggled to keep going when he was not up to par to handle it. It was a very lonely time for her. She was also very concerned about safety as he would often lose concentration whilst driving.

After the testosterone implants she says he was improved in all ways, which was a tremendous relief for her

The couple live in a modest old weatherboard cottage in Bowraville, which they are buying at a fortnightly mortgage payment of $216. Their total income at that time was just $608.60 a fortnight.

Peter was therefore concerned to hear about the proposed change of rules regarding subsidy. If he couldn’t meet the new punitive criteria he would have to pay between $400— $450 for the pellets next time, a sum totally out of his reach.

When the rules came in and he did not qualify, his doctor Dr Andrew Heslop, wrote to the PBAC pointing out that Peter had previously been on the treatment, that he had had an excellent clinical response and requesting that he be allowed to continue on Authority forPBS subsidy. This was declined.

As the effect of the implanted pellets wore off, all Peters old symptoms returned but at a much faster rate than originally. His descent from wellbeing to debility, which had originally occurred gradually over years of decline, took just 3-4 months to re-appear.

Information gathered under P01 reveals that the PBAC knew that anyone already qualified and on treatment under the previous criteria and who then had treatment withdrawn would suffer this distressing crash. They nevertheless inhumanely decided against a grandfather clause that would have allowed those already legitimately diagnosed to continue with subsidised treatment.

Peter describes the crash as a "living nightmare". He describes waking up feeling terrible, legs cramped up, anxiety attacks and severe depression, severe skin problems with dry cracking skin and eczema as well as the return of all his previous debilitating symptoms and return of other the health problems that had cleared up whilst. he was on supplementation.

Peter himself petitioned everyone he could from the Minister, the Department of Health and Aged Care, the PSAC, his own MP, the other political parties and the Endocrine Society. He also began to search the Internet and discovered in his own words that "the world is awash with scientific papers to support the use of testosterone supplementation when supported by clinical examination and pathology with reference to the Free Androgen Index1’. (Neither clinical observation nor PAl is taken into account under the Australian government changes)

In WA we know of at least one man who was given an authority for PBS subsidised prescription after his doctor wrote to the PBAC, even though he did not meet the new qualifying criteria.

It had also been discovered that the results provided to doctors were in any case only approximate - with a recognised error margin of 2.5 nmols (ie an error factor of over 25% against the required level of 8nmols) within a single laboratory and a variance of up to 5 nmols between different laboratories.

In view of both the above, Peters doctor therefore wrote to the PBAC a second time but was again refused.

Key Points of Case Study

In refusing to take into account the 2.5 umols per litre margin of error inherent in the testing process , the government has denied Mr Allen access to natural justice in that he has been refused medication he needs to function normally in life - not on the basis of his medical status but on a pure random chance factor.

We have evidence that in at least one other case the rules have been waived to allow a man to receive the subsidy on the request of his doctor notwithstanding the fact that he did not meet the rigid criteria. He was further outside than Mr Allen

Mr Allen has therefore received less than equitable treatment.

Information gained under FOI has revealed that the process for setting the criteria imposed upon Mr Allen was flawed. Even though the criteria was later endorsed by a paper from the Endocrine Society no supporting scientific data was provided in that paper to justify opinion agreeing with the government’s criteria content and level.

Since this opinion is at odds with international expert opinion and there are other factors which indicate that undue influence could have been brought to bear in this case, an independent review is warranted. This is particularly so when the government has chosen to totally exclude the opinion of each man’s treating doctor.

The hearing on 15 February 2001 determined that the MT does not have jurisdiction but indicated that a review should be sought under ADJR.